Related Experiment Video
Updated: Jan 28, 2026

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
Published on: September 18, 2013
Conservation of structure, function and inhibitor binding in UNC-51-like kinase 1 and 2 (ULK1/2)
Apirat Chaikuad1,2, Sebastian E Koschade3,4, Alexandra Stolz2,5
1Institute of Pharmaceutical Chemistry, Goethe-University Frankfurt, 60438 Frankfurt, Germany knapp@pharmchem.uni-frankfurt.de chaikuad@pharmchem.uni-frankfurt.de.
Abstract:
Autophagy is essential for cellular homeostasis and when deregulated this survival mechanism has been associated with disease development. Inhibition of autophagy initiation by inhibiting the kinase ULK1 (Unc-51-like autophagy activating kinase 1) has been proposed as a potential cancer therapy. While inhibitors and crystal structures of ULK1 have been reported, little is known about the other closely related kinase ULK2 (Unc-51-like autophagy activating kinase 2). Here, we present the crystal structure of ULK2 in complex with ATP competitive inhibitors. Surprisingly, the ULK2 structure revealed a dimeric assembly reminiscent of dimeric arrangements of auto-activating kinases suggesting a role for this association in ULK activation. Screening of a kinase focused library of pre-clinical and clinical compounds revealed several potent ULK1/2 inhibitors and good correlation of inhibitor-binding behavior with both ULK kinases. Aurora A was identified as a major off-target of currently used ULK1 inhibitors. Autophagic flux assays demonstrated that this off-target activity by strongly inducing autophagy in different cellular systems conferred an additional layer of complexity in the interpretation of cellular data. The data presented here provide structural models and chemical starting points for the development of ULK1/2 dual inhibitors with improved selectivity for future exploitation of autophagy inhibition.
Insights
Researchers explored ULK2 kinase structure and identified dual ULK1/2 inhibitors for cancer therapy. Off-target effects on Aurora A were noted, impacting autophagy studies and highlighting the need for selective inhibitors.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Autophagy is crucial for cellular balance, but its dysregulation is linked to diseases, including cancer.
- Inhibiting ULK1 (Unc-51-like autophagy activating kinase 1) is a potential cancer therapy strategy, but ULK2 (Unc-51-like autophagy activating kinase 2) remains less understood.
Purpose of the Study:
- To determine the crystal structure of ULK2 in complex with inhibitors.
- To identify potent dual ULK1/2 inhibitors and assess their selectivity.
- To investigate off-target effects of ULK1 inhibitors.
Main Methods:
- X-ray crystallography was used to obtain the ULK2-inhibitor complex structure.
- A focused kinase library was screened for ULK1/2 inhibitors.
- Off-target analysis identified Aurora A as a target of ULK1 inhibitors.
- Autophagic flux assays were performed to evaluate cellular effects.
Main Results:
- The ULK2 crystal structure revealed a dimeric assembly, suggesting a role in kinase activation.
- Several potent ULK1/2 inhibitors were identified with conserved binding.
- Aurora A was identified as a significant off-target of ULK1 inhibitors, inducing autophagy.
- Off-target activity complicates the interpretation of cellular autophagy data.
Conclusions:
- Structural insights into ULK2 provide a basis for developing dual ULK1/2 inhibitors.
- Current ULK1 inhibitors have off-target effects on Aurora A, impacting autophagy research.
- Development of selective ULK1/2 inhibitors is crucial for effective autophagy-targeted therapies.
Related Concept Videos
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Conserved Binding Sites
Predicting Products: SN1 vs. SN2
With increased substitution on the alkyl halide,...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
2° Amines to N-Nitrosamines: Reaction with NaNO2

